Valuation (71%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 7.66 | N/A |
| PEG Ratio (TTM) | -8.96 | N/A |
| P/S Ratio (TTM) | 6.38 | N/A |
| P/B Ratio (TTM) | 0.96 | N/A |
| P/FCF Ratio (TTM) | 8.90 | N/A |
| Price to 5YR AVG Earnings Ratio | 20.71 | N/A |
| Price to 5YR AVG FCF Ratio | 17.23 | N/A |
Profitability (60%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 7.56% | N/A |
| ROE (TTM) | 12.57% | N/A |
| Net Profit Margin (TTM) | 83.38% | N/A |
| ROIC 5YR AVG | 4.03% | N/A |
Growth (57%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -0.06% | -125.21% | 10.16% |
| Revenue | 38.36% | -117.07% | 89.04% |
| Net Income | 40.07% | -126.86% | 59.99% |
| Cash Flow | 1.05% | 372.89% | 260.07% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.83 | N/A |
| Quick Ratio (TTM) | 0.83 | N/A |
| D/E Ratio (TTM) | 0.38 | N/A |
| Interest Coverage (TTM) | 6.61 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 1.03 | N/A |
| LTL to 5YR AVG FCF | 6.88 | N/A |
| Shares Outstanding Growth 5YR AVG | 27.01% | N/A |